A Dual‐Target Recognition System Based on Acid‐Degradable Ni‐MOF and Aptamer Guidance for Precise Tumor Diagnosis and Combined Therapy
Advanced Science · 2025-11 · 12 (42)
DOI: 10.1002/advs.202512838 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 24.09.2025. Verfasst von Jing Xu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710004, China. Hauptthemen laut MEDLINE: Metal-Organic Frameworks, Nickel, Aptamers, Nucleotide, Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Joint Fund Project for Technology Research and Development Plan of Henan Technology (Young Scientists).
Abstract (Originalsprache)
Inherent heterogeneity of tumors significantly limits the therapeutic efficacy of existing cancer treatment systems. This work proposes a dual‐targeting theranostic system based on acid‐responsive cleavage of a metal‐organic framework (MOF). By functionalizing the MOF with dual aptamers that exhibit strict base complementarity to cancer cell biomarkers, the system achieves synergistic passive and active targeting, significantly improving the recognition accuracy for cancer cells. Simultaneously, leveraging the glucose‐dependent metabolic features of tumor cells, the system efficiently catalyzes the generation of hydroxyl radicals (·OH) from glucose, thereby activating chemodynamic therapy. Furthermore, under infrared light irradiation, nickel (Ni) atoms doped within the MOF generate a photothermal effect, further enhancing the inactivation of cancer cells. Both in vitro and in vivo experiments confirm the high efficiency of this system for diagnosis and therapy. The photothermal effect of the MOF material is validated using density functional theory (DFT) calculations, and the therapeutic efficacy is evaluated using a machine learning‐based approach, further demonstrating the system's potential for in vivo therapeutic application. This study provides a novel strategy for precise cancer diagnosis and therapy, offering promising potential to overcome the limitations of existing systems and provide new avenues for cancer theranostics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710004, China.
- School of Chemistry and Chemical Engineering, Yangzhou University, Yangzhou, 225009, China.
ORCID-Profile: Huan Pang
Förderung
- National Natural Science Foundation of China
- Joint Fund Project for Technology Research and Development Plan of Henan Technology (Young Scientists)
Zitieren
APA
Xu, J., Chen, H., Tao, Y., Wang, H., Wang, Z., Xue, Y., Fu, D., Pang, H., & Xue, L. (2025). A Dual‐Target Recognition System Based on Acid‐Degradable Ni‐MOF and Aptamer Guidance for Precise Tumor Diagnosis and Combined Therapy. Advanced Science, 12(42). https://doi.org/10.1002/advs.202512838
Vancouver
Xu J, Chen H, Tao Y, Wang H, Wang Z, Xue Y, et al. A Dual‐Target Recognition System Based on Acid‐Degradable Ni‐MOF and Aptamer Guidance for Precise Tumor Diagnosis and Combined Therapy. Advanced Science. 2025;12(42). doi:10.1002/advs.202512838
BibTeX
@article{Xu2025,
author = {Xu, Jing and Chen, Hanxiao and Tao, Yifang and Wang, Hong and Wang, Zhenlong and Xue, Yuquan and Fu, Delai and Pang, Huan and Xue, Li},
title = {A Dual‐Target Recognition System Based on Acid‐Degradable Ni‐MOF and Aptamer Guidance for Precise Tumor Diagnosis and Combined Therapy},
journal = {Advanced Science},
year = {2025},
volume = {12},
number = {42},
doi = {10.1002/advs.202512838}
}
EUVIMED